After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
How does India look from space? On hearing this question, everyone remembers Indian astronaut Rak
Tirupati Temple Laddu Scam: Prasad made with 68 lakh kg of fake ghee, what is the Rs 250 crore scam?
The former head of the temple board has been questioned in connection with the alleged adulterati
Realme Pad X 5G: Realme is gearing up to launch its most powerful tablet to date, the Realme Pad
PM Modi Garba Song: PM Modi wrote the Garba song, and shared it on the occasion of Navratri
Navratri is being celebrated with great pomp across the country. Prime Minister Narendra Modi on
Great discomfort in Bangladesh and Brazil for vaccine made in India
After the approval of the emergency use of two vaccines for the Coronavirus in India, countries l
Indian young sensation Vaibhav Suryavanshi faced jeering from Pakistani fans after the Under-19 A
PM Modi addressed a public meeting in Surguja, Chhattisgarh today. PM Modi mentioned inherit
Prime Minister Narendra Modi on Monday spoke to Uttarakhand Chief Minister Pushkar Singh Dhami ov
After Twitter, now Facebook and Instagram will also charge money for blue tick verification. Meta
The Reserve Bank of India on Tuesday announced the launch of the first pilot project of the retai
